Fenghe Lu

672 total citations
35 papers, 488 citations indexed

About

Fenghe Lu is a scholar working on Ophthalmology, Public Health, Environmental and Occupational Health and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Fenghe Lu has authored 35 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Ophthalmology, 13 papers in Public Health, Environmental and Occupational Health and 13 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Fenghe Lu's work include Glaucoma and retinal disorders (13 papers), Corneal surgery and disorders (13 papers) and Ocular Surface and Contact Lens (13 papers). Fenghe Lu is often cited by papers focused on Glaucoma and retinal disorders (13 papers), Corneal surgery and disorders (13 papers) and Ocular Surface and Contact Lens (13 papers). Fenghe Lu collaborates with scholars based in Canada, Japan and United States. Fenghe Lu's co-authors include Luigina Sorbara, Noriko Odani‐Kawabata, Desmond Fonn, Trefford Simpson, Makoto Aihara, Naveed Shams, A.N. Sherbourne, Kathy Liu, Auli Ropo and Najam A. Sharif and has published in prestigious journals such as The Plant Journal, American Journal of Ophthalmology and International Journal of Solids and Structures.

In The Last Decade

Fenghe Lu

34 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fenghe Lu Canada 12 314 237 233 155 57 35 488
Steven T. Simmons United States 11 624 2.0× 173 0.7× 274 1.2× 68 0.4× 44 0.8× 15 664
Semira Kaya Austria 16 577 1.8× 263 1.1× 457 2.0× 25 0.2× 28 0.5× 20 827
Ruth D. Williams United States 4 778 2.5× 124 0.5× 538 2.3× 63 0.4× 32 0.6× 6 826
Giuseppe Ferreri Italy 14 293 0.9× 362 1.5× 318 1.4× 37 0.2× 10 0.2× 32 629
M. Hossein Nowroozzadeh Iran 18 556 1.8× 113 0.5× 583 2.5× 256 1.7× 13 0.2× 82 879
Neil T Choplin United States 11 1.1k 3.5× 255 1.1× 725 3.1× 51 0.3× 58 1.0× 17 1.2k
Shiro Mizoue Japan 13 413 1.3× 204 0.9× 325 1.4× 18 0.1× 10 0.2× 38 516
R A Moses Taiwan 14 387 1.2× 97 0.4× 366 1.6× 64 0.4× 9 0.2× 25 550
Ying-Cheng Shen Taiwan 13 276 0.9× 50 0.2× 128 0.5× 45 0.3× 32 0.6× 18 409
Kevin H. Merkley United States 11 258 0.8× 76 0.3× 229 1.0× 119 0.8× 11 0.2× 25 378

Countries citing papers authored by Fenghe Lu

Since Specialization
Citations

This map shows the geographic impact of Fenghe Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fenghe Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fenghe Lu more than expected).

Fields of papers citing papers by Fenghe Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fenghe Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fenghe Lu. The network helps show where Fenghe Lu may publish in the future.

Co-authorship network of co-authors of Fenghe Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Fenghe Lu. A scholar is included among the top collaborators of Fenghe Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fenghe Lu. Fenghe Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Changfu, Yuanjun Li, J Wang, et al.. (2024). An independent biosynthetic route to frame a xanthanolide‐type sesquiterpene lactone in Asteraceae. The Plant Journal. 121(2). e17199–e17199. 3 indexed citations
2.
Aung, Tin, Da‐Wen Lu, Sirisha Senthil, et al.. (2024). Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial. Clinical ophthalmology. Volume 18. 2093–2106. 2 indexed citations
3.
Sharif, Najam A., Noriko Odani‐Kawabata, Fenghe Lu, & Leonard Pinchuk. (2023). FP and EP2 prostanoid receptor agonist drugs and aqueous humor outflow devices for treating ocular hypertension and glaucoma. Experimental Eye Research. 229. 109415–109415. 18 indexed citations
4.
Wirta, David, Yasuaki Kuwayama, Fenghe Lu, Hui Shao, & Noriko Odani‐Kawabata. (2022). Phase 2b, Randomized, 3-Month, Dose-Finding Study of Sepetaprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: The ANGEL Study. Journal of Ocular Pharmacology and Therapeutics. 38(3). 240–251. 9 indexed citations
5.
Olander, Kenneth W., Gary Jerkins, Fenghe Lu, et al.. (2020). A randomized Phase 2 trial assessing the safety and efficacy of omidenepag isopropyl 0.002% once and twice daily in subjects with primary open-angle glaucoma or ocular hypertension (Spectrum 6). Investigative Ophthalmology & Visual Science. 61(7). 4258–4258. 1 indexed citations
6.
Aihara, Makoto, Fenghe Lu, Yuki Tanaka, et al.. (2019). Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study). Journal of Ocular Pharmacology and Therapeutics. 35(10). 542–550. 22 indexed citations
7.
Lu, Fenghe, et al.. (2018). A Phase 3 trial comparing omidenepag isopropyl 0.002% with latanoprost 0.005% in primary open-angle glaucoma and ocular hypertension: the AYAME study. Investigative Ophthalmology & Visual Science. 59(9). 1235–1235. 7 indexed citations
8.
Ropo, Auli, et al.. (2018). IOP lowering effect of omidenepag isopropyl in latanoprost non-/low-responder subjects with primary open-angle glaucoma or ocular hypertension: the FUJI study. Investigative Ophthalmology & Visual Science. 59(9). 1233–1233. 2 indexed citations
9.
Aihara, Makoto, et al.. (2018). Six-month efficacy and safety outcomes of a novel selective EP2 agonist omidenepag isopropyl: the RENGE study (Phase 3). Investigative Ophthalmology & Visual Science. 59(9). 1229–1229. 5 indexed citations
10.
Aihara, Makoto, Fenghe Lu, Yuki Tanaka, et al.. (2017). Pharmacokinetics, Safety and IOP Lowering Profiles of omidenepag isopropyl, a Selective EP2 Agonist in Healthy Japanese and Caucasian Volunteers (Phase I Study). Investigative Ophthalmology & Visual Science. 58(8). 2104–2104. 5 indexed citations
11.
Lu, Fenghe, et al.. (2015). Safety and Efficacy of DE-117, a Selective EP2 Agonist in a Phase 2a Study. Investigative Ophthalmology & Visual Science. 56(7). 5708–5708. 9 indexed citations
12.
Lu, Fenghe, Trefford Simpson, Luigina Sorbara, & Desmond Fonn. (2008). Malleability of the Ocular Surface in Response to Mechanical Stress Induced by Orthokeratology Contact Lenses. Cornea. 27(2). 133–141. 34 indexed citations
13.
Lu, Fenghe, Trefford Simpson, Luigina Sorbara, & Desmond Fonn. (2007). The relationship between the treatment zone diameter and visual, optical and subjective performance in Corneal Refractive Therapy™ lens wearers 1. Ophthalmic and Physiological Optics. 27(6). 568–578. 46 indexed citations
14.
Lu, Fenghe, Luigina Sorbara, Trefford Simpson, & Desmond Fonn. (2007). Corneal Shape and Optical Performance After One Night of Corneal Refractive Therapy for Hyperopia. Optometry and Vision Science. 84(4). 357–364. 15 indexed citations
15.
Lu, Fenghe, Trefford Simpson, Luigina Sorbara, & Desmond Fonn. (2007). Corneal Refractive Therapy with Different Lens Materials, Part 2: Effect of Oxygen Transmissibility on Corneal Shape and Optical Characteristics. Optometry and Vision Science. 84(4). 349–356. 16 indexed citations
16.
Lu, Fenghe, Trefford Simpson, Desmond Fonn, Luigina Sorbara, & Lyndon Jones. (2006). Validity of Pachymetric Measurements by Manipulating the Acoustic Factor of Orbscan II. Eye & Contact Lens Science & Clinical Practice. 32(2). 78–83. 8 indexed citations
17.
Sorbara, Luigina, Fenghe Lu, Desmond Fonn, & Trefford Simpson. (2005). Topographic Keratometric Effects of Corneal Refractive Therapy for Hyperopia After One Night of Lens Wear. Investigative Ophthalmology & Visual Science. 46(13). 2061–2061. 2 indexed citations
18.
Sorbara, Luigina, et al.. (2005). Reduction of Myopia From Corneal Refractive Therapy. Optometry and Vision Science. 82(6). 512–518. 55 indexed citations
19.
Lu, Fenghe, Trefford Simpson, Luigina Sorbara, Desmond Fonn, & Lyndon Jones. (2004). The relationship between the treatment zone diameter and visual, optical and subjective performance in CRTTM lens wearers. Investigative Ophthalmology & Visual Science. 45(13). 1576–1576. 2 indexed citations
20.
Lu, Fenghe, et al.. (2003). Topographic Keratometric Effects of Corneal Refractive Therapy After One Night of Lens Wear. Investigative Ophthalmology & Visual Science. 44(13). 3699–3699. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026